• 1
    Perez Velasco R, Praditsitthikorn N, Wichmann K et al. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One 2012; 7:e30333.
  • 2
    World Health Organization. Pandemic Influenza Preparedness and Response: a WHO Guidance Document. Geneva, Switzerland: World Health Organization, 2009.
  • 3
    Cooper N, Coyle D, Abrams K, Mugford M, Sutton A. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. J Health Serv Res Policy 2005; 10:245250.
  • 4
    Lee VJ, Phua KH, Chenm MI et al. Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Emerg Infect Dis 2006; 12:95102.
  • 5
    Newall AT, Wood JG, Oudin N, MacIntyre CR. Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies. Emerg Infect Dis 2010; 16:224230.
  • 6
    Durbin A, Corallo AN, Wibisono TG et al. A cost effectiveness analysis of the H1N1 vaccine strategy for Ontario, Canada. J Infect Dis Immun 2011; 3:4049.
  • 7
    Prosser LA, Lavelle TA, Fiore AE et al. Cost-effectiveness of 2009 pandemic influenza A (H1N1) vaccination in the United States. PLoS One 2011; 6:e22308.
  • 8
    Sander B, Nizam A, Garrison LP et al. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health 2009; 12:226233.
  • 9
    Lugnér AK, Boven Mv, Vries Rd, Postma MJ, Wallinga J. Cost-effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012; 12:e4445.
  • 10
    Yarmand H. Cost-effectiveness analysis of vaccination and self-isolation in case of an H1N1 outbreak [Dissertation]. Raleigh, NC: North Carolina State University, 2010.
  • 11
    Piercy J, Miles A. The Economics of Pandemic Influenza in Switzerland. Bern, Switzerland: Federal Office of Public Health, 2003.
  • 12
    Khazeni N, Hutton DW, Garber AM, Owens DK. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med 2009; 151:840853.
  • 13
    Tuite AR, Greer AL, Whelan M et al. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. Can Med Assoc J 2010; 182:131136.
  • 14
    CDC Community Mitigation Strategy Team. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States—early, targeted, layered use of nonpharmaceutical interventions. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services, 2007.
  • 15
    Sander B, Bauch C, Fisman DN et al. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Early evidence from the Canadian experience. PLoS Curr 2009; 1:RRN1137.
  • 16
    Perlroth DJ, Glass RJ, Davey VJ et al. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis 2010; 50:165174.
  • 17
    Halder N, Kelso JK, Milne GJ. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics. PLoS One 2011; 6:e22087.
  • 18
    Pershad J, Waters TM. Use of tent for screening during H1N1 pandemic: impact on quality and cost of care. Pediatr Emerg Care 2012; 28:229235.
  • 19
    You JH, Chan ES, Leung MY, Ip M, Lee NL. A cost-effectiveness analysis of “test” versus “treat” patients hospitalized with suspected influenza in Hong Kong. PLoS One 2012; 7:e33123.
  • 20
    Araz OM, Damien P, Paltiel DA et al. Simulating school closure policies for cost effective pandemic decision making. BMC Public Health 2012; 12:449.
  • 21
    Chocontá-Piraquive LA, Alvis Guzman N, De la Hoz Restrepo F. Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia. Rev Panam Salud Publica 2012; 31:447453.
  • 22
    Gottschalk R, Bellinger O, Stadthagen S et al. Costs of the influenza pandemic for the public health services - calculations based on the model of the metropolitan region Frankfurt am Main. Pneumologie 2011; 65:697704.
  • 23
    Giglio ND, Castellano VE, Ruttimann RW, Vidal GI, Gentile A. Impact on the direct medical cost related to the influenza virus during 2009 in children under 5 years compared to the period 2006-2008 in a pediatric hospital. Arch Argent Pediatr 2012; 110:1926.
  • 24
    Galante M, Garin O, Sicuri E et al. Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS One 2012; 7:e31696.
  • 25
    Zarogoulidis P, Glaros D, Kontakiotis T et al. Health costs from hospitalization with H1N1 infection during the 2009–2010 influenza pandemic compared with non-H1N1 respiratory infections. Int J Gen Med 2012; 5:175182.